Abstract
Perthiolated β-cyclodextrin-based nanocapsules incorporating diaquo GdIII-complexes represent a promising new type of bioresponsive MRI contrast agent, showing a pronounced relaxivity change upon degradation in a reducing environment.
Original language | English |
---|---|
Pages (from-to) | 3144-3146 |
Number of pages | 3 |
Journal | Chemical Communications |
Volume | 47 |
Issue number | 11 |
DOIs | |
Publication status | Published - 1 Mar 2011 |